The Online International  Journal of Onco Scientific Networks & Oncology is a peer-reviewed open acess journal that publishes original research articles as well as review articles in all areas of Oncology. this practical journal also includes information on new products, new therapies and patient management, as well as reviews of the latest research. Cancer is a complex problem. The international effort to understand and control it involves clinicians trained in many branches of medicine and scientists from most biological disciplines, chemistry, pharmaceutical and physical sciences The International Online Journal of Cancer & Therapeutics exists to serve the needs of this diverse community, providing a forum for prompt communication of original and innovative research findings that have relevance to understanding the etiology of cancer and to improving the treatment and survival of patients.

The journal publishes important original studies, reviews, and perspectives within the major topic areas of biology of premalignancy, risk factors and risk assessment, early detection research, immunoprevention, and chemopreventive and other interventions, including the basic science behind them. This journal comprises preclinical, clinical and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences. Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.

Oncology is the diagnosis and treatment of cancers,including breast,prostate,colon,lung and ovarian cancers as well as brain tumors,leukemia,lymphoma and many other types of cancer.. A doctor who works in the field of oncology is called an oncologist. The primary regions of oncology are radiation, which is worried with radiation treatment, or radiotherapy; surgical, which is contained specialists who spend significant time in tumor evacuation; therapeutic, which manages disease drugs, including chemotherapy; and interventional, which includes interventional radiologists who have some expertise in insignificantly obtrusive picture guided tumor treatment.




Fang zhang

Assistant Chief Physician

  • 2000.9--2005.7 Weifang Medical College, Five-year full-time clinical medicine, MD  (Bachelor's degree recognized )
  • 2005.9-2008.6   Dalian Medical University, three-year full-time, Oncology,  Master of Science degree(MS)
  • 2012.9-2014. Shandong University, Clinical Medicine Doctor Degree(In-service)
  • At present   Assistant Chief Physician and serving as Weifang Medical College and Qilu Medical College clinical teaching officer&& Genetic counseling.
  • First Hospital of Zibo City youth backbone physician
  • Zibo youth top-notch medical expert
  • Zibo City Science and Technology Progress Award
  • Liaoning Province scientific and technological progress award


1 Lack of any Prognostic Value of Body Mass Index for Patients Undergoing Chemoradiotherapy for Esophageal Squamous Cell CarcinomaAsian Pac J Cancer Prev.

2 A retrospective study: the prevalence and prognostic value of anemia in patients undergoing radiotherapy for esophageal squamous cell carcinoma( recommended on Pubadvanced), World J Surg Oncol.

3 A retrospective study: the prognostic value of anaemia, smoking and drinking in esophageal squamous cell carcinoma with primary radiotherapy, World J Surg Oncol.

4 Two cases report of subcutaneous hemorrhage during Apatinib treatment and review of literature, Chinese Journal of Cancer(being submitted).